B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy

BACKGROUND: Despite the clinical response of conventional anticancer therapy, including chemotherapeutic treatments, radiation therapy and corticosteroids, tumorigenic B-cell lymphomas show an incomplete response to clinical practices that result in a minimal residual disease (MRD) where few residua...

Descripción completa

Detalles Bibliográficos
Autores principales: Migliaccio, Nunzia, Palmieri, Camillo, Ruggiero, Immacolata, Fiume, Giuseppe, Martucci, Nicola M, Scala, Iris, Quinto, Ileana, Scala, Giuseppe, Lamberti, Annalisa, Arcari, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433068/
https://www.ncbi.nlm.nih.gov/pubmed/25983658
http://dx.doi.org/10.1186/s12935-015-0202-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433068/
https://www.ncbi.nlm.nih.gov/pubmed/25983658
http://dx.doi.org/10.1186/s12935-015-0202-4

Ejemplares similares